Humoral immunity in myasthenia gravis: relationship to disease severity and steroid treatment.
D000818:Animals; D001327:Autoimmune Diseases / Q000276:immunology; D001666:Binding Sites, Antibody; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis*; D009157:Myasthenia Gravis / Q000188:drug therapy / Q000276:immunology*; D009469:Neuromuscular Junction / Q000276:immunology; D011241:Prednisone / Q000627:therapeutic use; D051381:Rats; D011978:Receptors, Nicotinic / Q000276:immunology
D002800:Cholinesterase Inhibitors; D007074:Immunoglobulin G; D011978:Receptors, Nicotinic; D011241:Prednisone